pulmonology

(redirected from Pulmonary diseases)
Also found in: Medical, Encyclopedia.
Related to Pulmonary diseases: COPD

pul·mo·nol·o·gy

 (po͝ol′mə-nŏl′ə-jē, pŭl′-)
n.
The branch of medicine that deals with diseases of the respiratory system.

[Latin pulmō, pulmōn-, lung; see pulmonary + -logy.]

pul′mo·nol′o·gist n.

pulmonology

(ˌpʌlmənˈɒlədʒɪ)
n
(Medicine) the branch of medical science concerned with the lungs and respiratory system and their diseases
ˌpulmonˈologist n
Translations

pulmonology

n neumología, rama de la medicina que se ocupa de los pulmones y sus enfermedades
References in periodicals archive ?
We are excited about these opportunities and remain focused on developing first-in-class therapies for patients suffering from serious chronic orphan pulmonary diseases in order to continue building long-term shareholder value," concluded Mr.
for POL6014, a clinical stage selective inhibitor of human neutrophil elastase with the potential to treat cystic fibrosis (CF) and other neutrophilic pulmonary diseases such as non-cystic fibrosis bronchiectasis (NCFB), alpha-1 antitrypsin deficiency (AATD) and primary ciliary dyskinesia (PCD).
Echocardiography in chronic obstructive pulmonary diseases.
Synspira is developing a new class of inhaled glycopolymer-based therapeutics to reduce pulmonary inflammation and infection, key drivers of pulmonary diseases including cystic fibrosis, chronic obstructive pulmonary disease, and pneumonia.
Obstructive pulmonary diseases include chronic obstructive pulmonary disease (COPD) that presents with chronic bronchitis or pulmonary emphysema, and cystic fibrosis (CF), an intractable hereditary disease characterised by mucus retention and chronic bacterial infection.
Collaboration is formed by Capsugel and Pulmatrix to develop and manufacture novel inhaled therapeutics for pulmonary diseases.
SeeNews) - Jul 1, 2014 - Belgian biotechnology firmA GalapagosA (EBR:GLPG) said Tuesday it would start a Phase I clinical trial with the GLPG1690 molecule aimed at treating pulmonary diseases.
US Centocor Ortho Biotech Inc, part of Johnson & Johnson (NYSE:JNJ), said today it has bought London-based RespiVert Ltd, a developer of drugs for the treatment of pulmonary diseases, for an undisclosed sum.
The former miner believes more must be done not just for ex-pitmen with coal-dust afflictions, but also for those with pulmonary diseases and breathing difficulties.
Pulmonary diseases often induce panic attacks, which could contribute to thoughts of killing oneself, comment internist Bruce L.
The study suggests ah interaction of genetic background with environmental exposure, and further suggests that intermediate responses are important in the development and progression of chronic pulmonary diseases such as coal workers' pneumoconiosis.